Discontinuation of Beta-Blocker Therapy after Myocardial Infarction
New England Journal of Medicine · 02.04.2026 · 394 (13) · 1302-1312
DOI: 10.1056/nejmoa2601005 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, erschienen am 02.04.2026. Verfasst von Ki Hong Choi und 38 weiteren Autor:innen. Beteiligte Einrichtung: Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Heart Failure, Myocardial Infarction, Withholding Treatment. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Patient-Centered Clinical Research Coordinating Center in the Ministry of Health & Welfare, Republic of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.
- Kyung Hee University Hospital, Seoul, South Korea.
- Inje University Ilsan Paik Hospital, Goyang, South Korea.
- Chonnam National University Hospital, Gwangju, South Korea.
- Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
ORCID-Profile: Ki Hong Choi, Joon-Hyung Doh, Sung Gyun Ahn, Chang-Wook Nam, Eun-Seok Shin, Joo Myung Lee, Joo-Yong Hahn
Förderung
- Ministry of Health and Welfare
- Patient-Centered Clinical Research Coordinating Center in the Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Choi, K. H., Kang, D., Kim, W., Doh, J. H., Kim, J., Park, Y. H., Ahn, S. G., Park, J. P., Kim, S. M., Cho, B. R., Nam, C. W., Cho, J. H., Joo, S. J., Suh, J., Jeong, J. O., Jang, W. J., Goh, C. W., Yoon, C. H., Hwang, J. Y., …, & SMART-DECISION Investigators (2026). Discontinuation of Beta-Blocker Therapy after Myocardial Infarction. New England Journal of Medicine, 394(13), 1302-1312. https://doi.org/10.1056/nejmoa2601005
Vancouver
Choi KH, Kang D, Kim W, Doh JH, Kim J, Park YH, et al. Discontinuation of Beta-Blocker Therapy after Myocardial Infarction. New England Journal of Medicine. 2026;394(13):1302-1312. doi:10.1056/nejmoa2601005
BibTeX
@article{Choi2026,
author = {Choi, Ki Hong and Kang, Danbee and Kim, Weon and Doh, Joon-Hyung and Kim, Juhan and Park, Yong Hwan and Ahn, Sung Gyun and Park, Jong Pil and Kim, Sang Min and Cho, Byung Ryul and Nam, Chang-Wook and Cho, Jang Hyun and Joo, Seung-Jae and Suh, Jon and Jeong, Jin-Ok and Jang, Woo Jin and Goh, Choong Won and Yoon, Chang-Hwan and Hwang, Jin-Yong and Lim, Seong-Hoon and Lee, Sang Rok and Shin, Eun-Seok and Kim, Byung Jin and Yu, Cheol Woong and Her, Sung-Ho and Kim, Hyun Kuk and Park, Kyu Tae and Kim, Juwon and Kim, Jihoon and Park, Taek Kyu and Lee, Joo Myung and Cho, Juhee and Yang, Jeong Hoon and Song, Young Bin and Choi, Seung-Hyuk and Gwon, Hyeon-Cheol and Guallar, Eliseo and Hahn, Joo-Yong and SMART-DECISION Investigators, SMART-DECISION Investigators},
title = {Discontinuation of Beta-Blocker Therapy after Myocardial Infarction},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {13},
pages = {1302--1312},
doi = {10.1056/nejmoa2601005}
}
EUVIMED